You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東誠藥業(002675.SZ):與通用電氣藥業簽署許可協議
格隆匯 10-21 18:13

格隆匯 10 月 21日丨東誠藥業(002675.SZ)公佈,20201021日,公司全資子公司南京江原安迪科正電子研究發展有限公司(“安迪科”)通用電氣藥業(上海)有限公司(GE HEALTHCARE (SHANGHAI) CO., LTD.)簽署了許可協議,授權安迪科中國大陸申請並持有藥品註冊證書、並在約定區域內產、[99mTc]替曲磷注射液,該產品為SPECT檢測冠心病的心肌灌注顯像,是目前歐美、日本心肌灌注主要核藥產品之一

公司下屬公司北京欣科思達醫藥科技有限公司(“北京欣科”)GE HEALTHCARE AS簽署了進口與分銷協議,授權北京欣科在中國大陸非獨家進口和經銷注射用亞錫替曲膦

協議簽訂後,公司全資子公司安迪科將擁有[99mTc]替曲磷注射液註冊證書以及在約定區域內的生產和經銷權,下屬公司北京欣科將擁有配套冷盒的非獨家經銷權。引入國外成熟原研產品,利於公司補強診斷藥物產品管線,拓寬收入和利潤來源。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account